SAIMA ALI: Open Payments
NPI 1134657794 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,996 in 41 payments from 17 companies in 2025. Trend: 2023 $771 · 2024 $951 · 2025 $1,996
Consulting: $1,200Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $1,200 |
| Amgen Inc. | 12 | $142 |
| Chiesi USA, Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $99 |
| Novo Nordisk Inc | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 2 | $47 |
| ABBVIE INC. | 2 | $37 |
| PFIZER INC. | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
Products named: JARDIANCE, ELFABRIO, OTEZLA, Ozempic, REPATHA, Wegovy, Cologuard Collection Kit, BREZTRI.
Industry payments across TX — which companies pay providers there.
